LINKSciences

The US timeline of COVID-19 from onset to national ~3 million patients.

COVID 19 Half Year Recap- Top State Ranked

COVID 19 Half Year Recap: Top Ranked Countries by Death.
Six-month anniversary of the COVID-19 outbreak. This updated timeline details the rank of death for top 15 countries.

COVID 19 Half Year Recap: Top Ranked Countries by Death June 29 2020 marks six-month anniversary of the COVID-19 outbreak. This updated timeline details the rank of death for top 15 countries.

The Status of Research: NIH Grant Report, Aug 2016 http://blog.linksciences.com/index.php/2016/09/27/the-status-of-research-nih-grant-report-aug-2016/

In June 2016, NIH awarded $2.7 billion funding in 7,030 grants to 6,206 P*s. California is the most awarded states. The Johns Hopkins University is the most awarded institution. Top awarded P*s are Gerson, Stanton; Pestell, Richard; and Holmes, King. - See more at: http://blog.linksciences.com/index.php/2016/07/26/the-status-of-research-nih-grant-report-june-2016/

The Status of Research: NIH Grant Report, June 2016 | Blog LINKSciences The Status of Research: NIH Grant Report, June 2016 Posted on July 26, 2016 by LINKSciences June 2016 Summary | In June 2016, NIH awarded $2.7 billion funding in 7,030 grants to 6,206 P*s. California is the most awarded states. The Johns Hopkins University is the most awarded institution. Top awarde...

The Snapshot of Erk1: Antibody Citation, Research Trend, and Expert Distribution.

http://blog.linksciences.com/index.php/2016/05/02/erk1-research-trend-expert-distribution-and-antibody-citation/

ERK1: Research Trend, Expert Distribution, and Antibody Citation | Blog LINKSciences ERK1: Research Trend, Expert Distribution, and Antibody Citation Posted on May 2, 2016 by LINKSciences ERK1, encoded by MAPK3 mitogen-activated protein kinase 3 (MAPK3) also known as ERT2; ERK-1; PRKM3; P44ERK1; P44MAPK; HS44KDAP; HUMKER1A; p44-ERK1; p44-MAPK. ERK1 is a member of the MAP kinase fami...

Apr 2016: NIH funding $3.2b, grants 7,475, PI 6,654. California, the most awarded state.
http://blog.linksciences.com/index.php/2016/05/24/the-status-of-research-nih-grant-report-april-2016/

The Status of Research: NIH Grant Report, April 2016 | Blog LINKSciences The Status of Research: NIH Grant Report, April 2016 Posted on May 24, 2016 by LINKSciences April 2016 Summary | In April 2016, NIH awarded $3.2 billion funding in 7,475 grants to 6,654 P*s. California is the most awarded states. The Johns Hopkins University is the most awarded institution. Top awar...

CD19: Research Trend, Expert Distribution, and Antibody Citation - See more at: http://blog.linksciences.com/index.php/2016/05/02/cd19-research-trend-expert-distribution-and-antibody-citation/

CD19: Research Trend, Expert Distribution, and Antibody Citation | Blog LINKSciences

The Snapshot of c-Myc: Antibody Citation, Research Trend, and Expert Distribution.

http://blog.linksciences.com/index.php/2016/04/19/c-myc-antibody-citation-research-trend-and-expert-distribution/

The Snapshot of c-Myc: Antibody Citation, Research Trend, and Expert Distribution | Blog... The Snapshot of c-Myc: Antibody Citation, Research Trend, and Expert Distribution Posted on April 19, 2016 by LINKSciences c-Myc is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor tha…

The Status of Research is strong, as NIH funding goes up.
http://blog.linksciences.com/index.php/2016/04/14/nih-grant-report-march-2016/

The Status of Research: NIH Funding Report, March 2016 | Blog LINKSciences The Status of Research: NIH Funding Report, March 2016 Posted on April 14, 2016 by LINKSciences March 2016 Summary | In March 2016, NIH awarded $1.6 billion funding in 3,927 grants to 3,600 P*s. California is the most awarded state, Johns Hopkins is the most awarded institution, top awarded P*s are…

TIM-3 is an emerging target beside PD-1. View its research trend. http://goo.gl/qexDgY

Immunotherapy: PD-1 says goodbye, TIM-3 says hello : Nature Reviews Clinical Oncology : Nature... Article preview View full access options Nature Reviews Clinical Oncology | Research Highlight Print Share/bookmark Cite U Like Facebook Twitter Delicious Digg Google+ LinkedIn Reddit StumbleUpon Previous article Nature Reviews Clinical Oncology | Research Highlights Gastrointestinal cancer: PICCOLO…

How rare is Chordoma? Only 27 research groups are studying it.
http://linksciences.com/showTheseProjects.do?projectKeyword=Chordoma

Chordoma is a cancer that forms along the spine or at the base of the skull. Here's information about a clinical trial testing a new vaccine that may help treat patients with this rare cancer: http://1.usa.gov/236AWXP